The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-10-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1002/ctm2.527 |
_version_ | 1797985717479014400 |
---|---|
author | Xiaochen Fei Liancheng Fan Wei Chen Wei Chen Yiming Gong Xinxing Du Yanqing Wang Yinjie Zhu Jiahua Pan Fangqin Wang Wanbing Zhao Tongtong Liu Yining Yang Baijun Dong Wei Xue |
author_facet | Xiaochen Fei Liancheng Fan Wei Chen Wei Chen Yiming Gong Xinxing Du Yanqing Wang Yinjie Zhu Jiahua Pan Fangqin Wang Wanbing Zhao Tongtong Liu Yining Yang Baijun Dong Wei Xue |
author_sort | Xiaochen Fei |
collection | DOAJ |
first_indexed | 2024-04-11T07:22:28Z |
format | Article |
id | doaj.art-c977e246e0d84390869ce0a39c3c7db2 |
institution | Directory Open Access Journal |
issn | 2001-1326 |
language | English |
last_indexed | 2024-04-11T07:22:28Z |
publishDate | 2021-10-01 |
publisher | Wiley |
record_format | Article |
series | Clinical and Translational Medicine |
spelling | doaj.art-c977e246e0d84390869ce0a39c3c7db22022-12-22T04:37:10ZengWileyClinical and Translational Medicine2001-13262021-10-011110n/an/a10.1002/ctm2.527The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter studyXiaochen Fei0Liancheng Fan1Wei Chen2Wei Chen3Yiming Gong4Xinxing Du5Yanqing Wang6Yinjie Zhu7Jiahua Pan8Fangqin Wang9Wanbing Zhao10Tongtong Liu11Yining Yang12Baijun Dong13Wei Xue14Department of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Urology The First Affiliated Hospital of Wenzhou Medical University Zhejiang ChinaDepartment of Urology Zhongshan Hospital Shanghai Medical College Fudan University Shanghai ChinaDepartment of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai ChinaGloriousMedTechnologyCo. Ltd Shanghai ChinaGloriousMedTechnologyCo. Ltd Shanghai ChinaGloriousMedTechnologyCo. Ltd Shanghai ChinaGloriousMedTechnologyCo. Ltd Shanghai ChinaDepartment of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai Chinahttps://doi.org/10.1002/ctm2.527 |
spellingShingle | Xiaochen Fei Liancheng Fan Wei Chen Wei Chen Yiming Gong Xinxing Du Yanqing Wang Yinjie Zhu Jiahua Pan Fangqin Wang Wanbing Zhao Tongtong Liu Yining Yang Baijun Dong Wei Xue The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study Clinical and Translational Medicine |
title | The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study |
title_full | The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study |
title_fullStr | The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study |
title_full_unstemmed | The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study |
title_short | The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study |
title_sort | prevalence and clinical implication of rare germline deleterious alterations in chinese patients with prostate cancer a real world multicenter study |
url | https://doi.org/10.1002/ctm2.527 |
work_keys_str_mv | AT xiaochenfei theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT lianchengfan theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT weichen theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT weichen theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT yiminggong theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT xinxingdu theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT yanqingwang theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT yinjiezhu theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT jiahuapan theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT fangqinwang theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT wanbingzhao theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT tongtongliu theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT yiningyang theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT baijundong theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT weixue theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT xiaochenfei prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT lianchengfan prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT weichen prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT weichen prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT yiminggong prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT xinxingdu prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT yanqingwang prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT yinjiezhu prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT jiahuapan prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT fangqinwang prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT wanbingzhao prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT tongtongliu prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT yiningyang prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT baijundong prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT weixue prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy |